IP Verse

Il-15R Alpha Forms, Cells Expressing Il-15R Alpha Forms, And Therapeutic Uses Of Il-15R Alpha And Il-15/Il-15R Alpha Complexes

EP2911684

ADMUNE THERAPEUTICS LLC
Application Number
EP13849581A
Filing Date
Oct 23, 2013
Status
Granted And Under Opposition
May 17, 2019
Grant Date
Jun 19, 2019
External Links
Slate, Register

Biblio Summary

The patent EP2911684B1 was granted on Jun 19, 2019 by Admune Therapeutics Llc The patent is currently Granted And Under Opposition.

Oppositions Filed by other Companies on the Patent

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GRAF VON STOSCH, ANDREASMar 19, 2020WITHDRAWN

More Opposed Patents of Admune Therapeutics Llc

The table below shows the patents of Admune Therapeutics Llc that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2724728Complexes Of Il-15 And Il-15R Alpha And Uses ThereofOct 17, 20181

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents